#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer limited stage Erythema Brain abscess Urethral valves Metastatic malignant melanoma Neuropathic arthropathy Hepatobiliary cancer Blood iron increased Haemolytic uraemic syndrome Acute myeloid leukaemia recurrent Fms-like tyrosine kinase 3 positive Immunodeficiency common variable Acute respiratory distress syndrome Osteosarcoma recurrent Nephropathy More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Trials in Disease Nephrotic syndrome – Life with Disease Langerhans’ cell histiocytosis – Diagnostics Loeys-Dietz syndrome – Diagnostics Rhabdomyosarcoma recurrent – Life with Disease Retinoblastoma – Trials in Disease Chondrosarcoma metastatic – Treatment Shprintzen-Goldberg syndrome – Basic Information Hypereosinophilic syndrome – Basic Information Mucous membrane pemphigoid – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elraglusib Sacituzumab Tirumotecan Gozetotide Alf-18 MB-001 Mannitol Budesonide VRDN-003 ARFOLITIXORIN Osilodrostat Dinoprostone Nitrous Oxide Concizumab Mb-Cart20.1 Co-Trimoxazole Lidocaine Deferoxamine Mesilate Lifileucel NALDEMEDINE Isoleucine Bictegravir More therapies…

    Learn about Your Condition

    Meniscus operation Obstructive pancreatitis Hepatic neoplasm Alcoholism Dyspepsia Morning sickness High-grade B-cell lymphoma Endometrial stromal sarcoma Intestinal infarction Renal cell carcinoma Dementia with Lewy bodies Haemorrhage intracranial Cushing's syndrome Malignant melanoma stage IV Dementia Alzheimer's type More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Seasonal allergy

  • Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Seasonal allergy
    • Asthma
    • Conjunctivitis allergic
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Short‑course sublingual ITULAZAX birch pollen extract with Lactobacillus rhamnosus GG for patients with pollen‑associated food allergy

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Betula Verrucosa (108)
    Germany

  • Dose-finding study of sublingual immunotherapy with phleum pratense extract (vs sodium chloride) in patients with grass pollen allergic rhinitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Phleum Pratense
    • Sodium Chloride
    Spain

  • Study to Find the Best Dose of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis, with or without Asthma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Allergenic Extract Of Grass Pollen Mixture: Dactylis Glomerata, Festuca Pratensis, Lolium Perenne, Phleum Pratense And Poa Pratensis (1:1:1:1:1), Polymerised
    • Placebo
    Poland Spain

  • Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Seasonal allergy
    Investigated Drugs:
    • Allergenic Extract Of Grass Pollen Mixture: Dactylis Glomerata, Festuca Pratensis, Lolium Perenne, Phleum Pratense And Poa Pratensis (1:1:1:1:1), Polymerised
    • Placebo
    Poland Spain

  • Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Agrostis Stolonifera Pollen
    • Alternaria Alternata Extract
    • Anthoxanthum Odoratum
    Germany
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!